| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/07/2014 | US8624025 Antiviral agents |
| 01/07/2014 | US8623924 Compositions and methods for modulating metabolic pathways |
| 01/07/2014 | US8623923 Process for the preparation of ajoene |
| 01/07/2014 | US8623922 Bronchodilating Beta-agonist compositions and methods |
| 01/07/2014 | US8623921 Bis(thio-hydrazide amide) formulation |
| 01/07/2014 | US8623920 Method of treating post-surgical acute pain |
| 01/07/2014 | US8623919 Method of synthesizing S-allyl-cysteine analogues and their therapeutic application in treating myocardial infarction |
| 01/07/2014 | US8623918 Amino acid salts of prostaglandins |
| 01/07/2014 | US8623917 Uses of prostacyclin analogs |
| 01/07/2014 | US8623916 Polyunsaturated fatty acid and diol ester as an anti-acne agent |
| 01/07/2014 | US8623915 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses |
| 01/07/2014 | US8623914 Medical composition |
| 01/07/2014 | US8623913 Methods for treating restless legs syndrome |
| 01/07/2014 | US8623912 Fostriecin derivatives and the pharmaceutical uses thereof |
| 01/07/2014 | US8623911 Boron-containing small molecules as anti-protozoal agent |
| 01/07/2014 | US8623909 Prophylactic/therapeutic agents for lifestyle-related diseases |
| 01/07/2014 | US8623908 Use of tellurium compounds for inhibition of interleukin-converting enzyme |
| 01/07/2014 | US8623907 Herbicides |
| 01/07/2014 | US8623906 Carboxy isatin hydrazones and their esters as Shp2 inhibitors |
| 01/07/2014 | US8623905 Modulators of ATP-binding cassette transporters |
| 01/07/2014 | US8623903 Indolecarboxylic acid derivative having PGD2 receptor antagonistic activity |
| 01/07/2014 | US8623902 Microbiocides |
| 01/07/2014 | US8623901 Compounds for the treatment of CNS disorders |
| 01/07/2014 | US8623900 Amino alcohol derivatives and their therapeutic activities |
| 01/07/2014 | US8623899 Bis-benzimidazole derivatives as hepatitis C virus inhibitors |
| 01/07/2014 | US8623898 Glycine transporter inhibiting substances |
| 01/07/2014 | US8623897 Methods and compositions for treatment of diabetes and dyslipidemia |
| 01/07/2014 | US8623896 Insecticidal compounds |
| 01/07/2014 | US8623895 Mitotic kinesin inhibitors and methods of use thereof |
| 01/07/2014 | US8623894 Solid forms of N-[2,4-Bis(1,1-dimethyethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquioline-3-carboxamide |
| 01/07/2014 | US8623893 Pyridino-pyridinone derivatives, preparation and therapeutic use thereof |
| 01/07/2014 | US8623891 Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds |
| 01/07/2014 | US8623890 Nematocidal sulfonamides |
| 01/07/2014 | US8623889 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof |
| 01/07/2014 | US8623888 3-oxy-hydromorphone derivatives |
| 01/07/2014 | US8623887 Compounds |
| 01/07/2014 | US8623886 Phycotoxins and uses thereof |
| 01/07/2014 | US8623885 Fused tricyclic dual inhibitors of CDK 4/6 and FLT3 |
| 01/07/2014 | US8623884 Quinazolinedione derivatives as PARP inhibitors |
| 01/07/2014 | US8623883 4-phenylamino-quinazolin-6-yl-amides |
| 01/07/2014 | US8623882 Aciclovir and diclofenac combination therapy for functional somatic syndromes |
| 01/07/2014 | US8623881 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 01/07/2014 | US8623880 Fused pyrimidine-dione derivatives as TRPA1 modulators |
| 01/07/2014 | US8623879 1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivates and their use as PDE9A modulators |
| 01/07/2014 | US8623878 Use of allopurinol for the treatment of hand foot skin reaction |
| 01/07/2014 | US8623877 Substituted N-heteroaryl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
| 01/07/2014 | US8623876 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 01/07/2014 | US8623875 Isoxazoline insecticides |
| 01/07/2014 | US8623874 Method of treating neurodegenerative diseases |
| 01/07/2014 | US8623873 Substituted piperazines as CB1 antagonists |
| 01/07/2014 | US8623872 Quinazolinone derivatives as PARP inhibitors |
| 01/07/2014 | US8623871 Substituted biaryl compounds for inflammation and immune-related uses |
| 01/07/2014 | US8623870 Pyridazinone derivatives |
| 01/07/2014 | US8623869 Compounds useful as inhibitors of ATR kinase |
| 01/07/2014 | US8623868 Processes of making and using pharmaceutical formulations of antineoplastic agents |
| 01/07/2014 | US8623867 Cyclic amine BACE-1 inhibitors having a benzamide substituent |
| 01/07/2014 | US8623866 Nitrogen containing heteroaryl compounds |
| 01/07/2014 | US8623865 Acylpiperazinones and their use as pharmaceuticals |
| 01/07/2014 | US8623864 Thioridazine and derivatives thereof for reversing anti-microbial drug-resistance |
| 01/07/2014 | US8623863 Disubstituted azepan orexin receptor antagonists |
| 01/07/2014 | US8623862 Derivatives of N-[(1H-pyrazol-1-yl)aryl]-1H-indole or 1H-indazole-3-carboxamide, preparation thereof and applications thereof in therapeutics |
| 01/07/2014 | US8623861 Method of treating demyelination diseases |
| 01/07/2014 | US8623859 Bradykinin B1 antagonists |
| 01/07/2014 | US8623858 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 01/07/2014 | US8623857 N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1 |
| 01/07/2014 | US8623856 Phenoxy-azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators |
| 01/07/2014 | US8623854 Nuclear export inhibitors of topoisomerase II alpha |
| 01/07/2014 | US8623853 Treatment of cancers characterized by chromosomal rearrangement of the NUT gene |
| 01/07/2014 | US8623852 Topical methods and compositions for the treatment of eye diseases and conditions |
| 01/07/2014 | US8623851 Formoterol/steroid bronchodilating compositions and methods of use thereof |
| 01/07/2014 | US8623850 15, 16-methylene-17-(1′-propenyl)-17,3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative |
| 01/07/2014 | US8623849 Medicinal applications of benzoic acid hydrazones synthesized on the basis of steroidal tigogenin |
| 01/07/2014 | US8623848 Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods |
| 01/07/2014 | US8623847 Compositions for treatment of inflammatory diseases |
| 01/07/2014 | US8623846 Diazeniumdiolate cyclohexyl derivatives |
| 01/07/2014 | US8623845 Pharmaceutical composition for preventing or treating Diabetes mellitus comprising bisphophonates |
| 01/07/2014 | US8623844 Fosaprepitant dimeglumine intermediate, neutral fosaprepitant, and amorphous fosaprepitant dimeglumine and processes for their preparations |
| 01/07/2014 | US8623842 Hemostatic agent and method |
| 01/07/2014 | US8623841 Medical and nutritional applications of highly refined cellulose |
| 01/07/2014 | US8623840 Methods and compositions for inducing satiety |
| 01/07/2014 | US8623839 Compositions and methods for stabilized polysaccharide formulations |
| 01/07/2014 | US8623834 Compositions including triciribine and trastuzumab and methods of use thereof |
| 01/07/2014 | US8623826 Compositions and methods for treating centrally mediated nausea and vomiting |
| 01/07/2014 | US8623819 Therapy for complications of diabetes |
| 01/07/2014 | US8623643 Antisense oligonucleotide modulation of STAT3 expression |
| 01/07/2014 | US8623609 Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents |
| 01/07/2014 | US8623434 Astaxanthin-containing pet foods |
| 01/07/2014 | US8623431 Composition to enhance the bioavailability of curcumin |
| 01/07/2014 | US8623422 Combination treatment with strontium for the prophylaxis and/or treatment of cartilage and/or bone conditions |
| 01/07/2014 | US8623417 Therapeutic polymeric nanoparticles with mTOR inhibitors and methods of making and using same |
| 01/07/2014 | US8623413 Compositions and medical devices utilizing bioabsorbable liquid polymers |
| 01/07/2014 | US8623412 Abuse-resistant pharmaceutical compositions |
| 01/07/2014 | US8623411 Modified release compositions comprising tacrolimus |
| 01/07/2014 | US8623410 Modified release compositions comprising tacrolimus |
| 01/07/2014 | US8623409 Clonidine formulation |
| 01/07/2014 | US8623408 Cladribine formulations for improved oral and transmucosal delivery |
| 01/07/2014 | US8623407 Gabapentin-containing solid compositions and process for preparing the same |
| 01/07/2014 | US8623406 Stable pharmaceutical composition and methods of using same |
| 01/07/2014 | US8623401 Wafer formulation |
| 01/07/2014 | US8623399 Methods of producing mesoporous drug delivery implants |